急性失代偿期肝硬化交感神经激活、线粒体功能障碍与结局:代谢组学预后模型(CLIF-C MET)
该研究利用欧洲两个前瞻性多中心大队列(发现队列CANONIC n=831,验证队列PREDICT n=851),通过非靶向血清代谢组学筛选与28天死亡相关的代谢物并构建预后模型。包含4-羟基-3-甲氧基苯基乙二醇硫酸酯、半乳糖醛酸、己酰肉碱和年龄的模型1及包含4-羟基-3-甲氧基苯基乙二醇硫酸酯、己酰肉碱、胆红素、INR和年龄的模型2,在发现队列和验证队列中预测7、14、28天死亡的C-index均高于MELDNa评分,在ACLF患者中同样优于MELDNa。
要点
- CLIF-C MET模型包含反映系统性炎症、线粒体功能障碍和交感神经激活的代谢物,预测短期死亡优于MELDNa。
- 发现队列中模型1预测7、14、28天死亡的C-index分别为0.9267、0.9002、0.8424,模型2分别为0.9369、0.9206、0.8529。
- 在ACLF患者中,模型1和模型2预测入院后7、14、28天死亡均优于MELDNa。
核心结论
- 包含代谢物(CLIF-C MET)的模型反映系统性炎症、线粒体功能障碍和交感神经系统激活,预测短期死亡优于仅基于器官功能障碍的评分(如MELDNa),尤其在ACLF患者中。
研究设计与样本
- 研究探索了欧洲两个前瞻性多中心大型队列,CANONIC(发现队列,n=831)和PREDICT(验证队列,n=851),用于研究ACLF及ACLF的发展,采用非靶向血清代谢组学识别和验证可改进预后建模的代谢物。
主要发现
- 发现队列中,模型1和模型2预测入院后7、14、28天死亡的C-index分别为0.9267、0.9002、0.8424和0.9369、0.9206、0.8529,均高于MELDNa评分。
- 验证队列中,模型1和模型2预测入院后7、14、28天死亡的C-index分别为0.940、0.834、0.791和0.947、0.857、0.810,结果与发现队列相似。
- 在ACLF患者中,模型1和模型2预测入院后7、14、28天死亡均优于MELDNa。
- 4-羟基-3-甲氧基苯基乙二醇硫酸酯是去甲肾上腺素衍生物,可能来源于脑干对系统性炎症的反应;半乳糖醛酸和己酰肉碱与线粒体功能障碍相关。
关键数值与推荐
- 模型1仅包含三个预后代谢物(4-羟基-3-甲氧基苯基乙二醇硫酸酯、半乳糖醛酸、己酰肉碱)和年龄。
- 模型2围绕4-羟基-3-甲氧基苯基乙二醇硫酸酯、己酰肉碱、胆红素、国际标准化比值(INR)和年龄构建。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current prognostic scores of patients with acutely decompensated cirrhosis (AD), particularly those with acute-on-chronic liver failure (ACLF), underestimate the risk of mortality. This is probably because systemic inflammation (SI), the major driver of AD/ACLF, is not reflected in the scores. SI induces metabolic changes, which impair delivery of the necessary energy for the immune reaction. This investigation aimed to identify metabolites associated with short-term (28-day) death and to design metabolomic prognostic models. METHODS: Two prospective multicentre large cohorts from Europe for investigating ACLF and development of ACLF, CANONIC (discovery, n=831) and PREDICT (validation, n=851), were explored by untargeted serum metabolomics to identify and validate metabolites which could allow improved prognostic modelling. RESULTS: Three prognostic metabolites strongly associated with death were selected to build the models. 4-Hydroxy-3-methoxyphenylglycol sulfate is a norepinephrine derivative, which may be derived from the brainstem response to SI. Additionally, galacturonic acid and hexanoylcarnitine are associated with mitochondrial dysfunction. Model 1 included only these three prognostic metabolites and age. Model 2 was built around 4-hydroxy-3-methoxyphenylglycol sulfate, hexanoylcarnitine, bilirubin, international normalised ratio (INR) and age. In the discovery cohort, both models were more accurate in predicting death within 7, 14 and 28 days after admission compared with MELDNa score (C-index: 0.9267, 0.9002 and 0.8424, and 0.9369, 0.9206 and 0.8529, with model 1 and model 2, respectively). Similar results were found in the validation cohort (C-index: 0.940, 0.834 and 0.791, and 0.947, 0.857 and 0.810, with model 1 and model 2, respectively). Also, in ACLF, model 1 and model 2 outperformed MELDNa 7, 14 and 28 days after admission for prediction of mortality. CONCLUSIONS: Models including metabolites (CLIF-C MET) reflecting SI, mitochondrial dysfunction and sympathetic system activation are better predictors of short-term mortality than scores based only on organ dysfunction (eg, MELDNa), especially in patients with ACLF.
引用
- Weiss E, de la Peña-Ramirez C, Aguilar F, et al. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET). Gut. 2023. PMID: 36788015. doi:10.1136/gutjnl-2022-328708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。